HSP90AA1 and cancer: There has been enormous interest in the development of Hsp90 inhibitors with an acceptable safety profile for the treatment of several cancers (47), and should any of these possess the correct toxicity profile, we would suggest that there is a possibility to repurpose these Hsp90 inhibitors against noroviruses.